当前位置:首页 - 行情中心 - 硕世生物(688399) - 财务分析 - 现金流量表

硕世生物

(688399)

  

流通市值:34.30亿  总市值:34.30亿
流通股本:1.24亿   总股本:1.24亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金190,814,935.39106,262,689.99396,436,406.37292,105,131.01
  收到的税费返还18,322.1818,322.18387,765.27350,784.1
  收到其他与经营活动有关的现金6,677,487.262,369,721.8926,217,968.6423,785,862.22
  经营活动现金流入小计197,510,744.83108,650,734.06423,042,140.28316,241,777.33
  购买商品、接受劳务支付的现金52,363,734.233,495,013.8193,826,428.7869,672,483.56
  支付给职工以及为职工支付的现金84,576,450.9342,618,999.32167,506,784.26126,002,783.18
  支付的各项税费9,123,143.244,335,498.6419,369,175.914,362,146.03
  支付其他与经营活动有关的现金56,268,590.8930,849,199.33111,998,554.2886,779,411.59
  经营活动现金流出小计202,331,919.26111,298,711.1392,700,943.22296,816,824.36
  经营活动产生的现金流量净额-4,821,174.43-2,647,977.0430,341,197.0619,424,952.97
二、投资活动产生的现金流量:
  收回投资收到的现金620,174,908.4515,083,393.554,358,652,053.173,609,526,290.91
  取得投资收益收到的现金--39,950,360.79321,661.96
  处置固定资产、无形资产和其他长期资产收回的现金净额2,144,774.352,064,846.561,254,463.491,139,165.76
  收到的其他与投资活动有关的现金---1,416,802.94
  投资活动现金流入小计622,319,682.75517,148,240.114,399,856,877.453,612,403,921.57
  购建固定资产、无形资产和其他长期资产支付的现金50,546,760.4234,923,978.4364,453,069.0355,390,132.48
  投资支付的现金875,277,173.33626,028,900.274,528,690,051.034,012,153,960.04
  投资活动现金流出小计925,823,933.75660,952,878.74,593,143,120.064,067,544,092.52
  投资活动产生的现金流量净额-303,504,251-143,804,638.59-193,286,242.61-455,140,170.95
三、筹资活动产生的现金流量:
  取得借款收到的现金370,827,600231,077,600648,044,417551,500,000
  收到其他与筹资活动有关的现金---1,146,675.78
  筹资活动现金流入小计370,827,600231,077,600648,044,417552,646,675.78
  偿还债务支付的现金192,000,00085,000,000510,400,000332,900,000
  分配股利、利润或偿付利息支付的现金4,196,904.851,816,764.43293,067,102.5290,918,633.07
  支付其他与筹资活动有关的现金2,401,282.491,113,092.46,684,222.027,401,602.38
  筹资活动现金流出小计198,598,187.3487,929,856.83810,151,324.52631,220,235.45
  筹资活动产生的现金流量净额172,229,412.66143,147,743.17-162,106,907.52-78,573,559.67
四、汇率变动对现金及现金等价物的影响-2,100,581.71-3,108,610.55-1,443,103.41-1,448,843.26
五、现金及现金等价物净增加额-138,196,594.48-6,413,483.01-326,495,056.48-515,737,620.91
  加:期初现金及现金等价物余额483,513,064.12483,513,064.12810,008,120.6810,008,120.6
  期末现金及现金等价物余额345,316,469.64477,099,581.11483,513,064.12294,270,499.69
补充资料:
  净利润19,564,558.98--41,078,454.55-
  资产减值准备2,938,914.83-39,459,781.8-
  固定资产和投资性房地产折旧23,526,927.06-48,058,767.98-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧23,526,927.06-48,058,767.98-
  无形资产摊销1,102,037.54-2,293,889.53-
  长期待摊费用摊销1,922,795.63-28,460,562.04-
  处置固定资产、无形资产和其他长期资产的损失-535,015.75--102,432.88-
  固定资产报废损失5,936.06-3,180,301.55-
  公允价值变动损失-25,063,192.33--47,555,955.77-
  财务费用5,630,608.72-9,146,598.2-
  投资损失-4,203,633.14--6,979,477.81-
  递延所得税7,141,786.68-9,009,205.17-
  其中:递延所得税资产减少7,142,330.11-9,008,538.27-
    递延所得税负债增加-543.43-666.9-
  存货的减少1,738,558.9--8,245,468.91-
  经营性应收项目的减少-504,866,359.8--44,464,772.34-
  经营性应付项目的增加484,987,486.26-48,846,698.62-
  其他-194,488-365,099.47-
  现金的期末余额345,316,469.64-483,513,064.12-
  减:现金的期初余额483,513,064.12-810,008,120.6-
  现金及现金等价物的净增加额-138,196,594.48--326,495,056.48-
公告日期2026-08-282026-04-302026-04-232025-10-25
审计意见(境内)标准无保留意见
TOP↑